Remdesivir in Patients With Severe Kidney Dysfunction: A Secondary Analysis of the CATCO Randomized Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 36036936.
- Also identified by DOI 10.1001/jamanetworkopen.2022.29236 and PMC identifier 9425145.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This secondary analysis of a randomized clinical trial examines the risk of kidney or hepatic toxic effects among patients with impaired kidney function at baseline treated with remdesivir.
Medical subject headings
- Alanine
- Kidney
- Kidney Diseases